AI assistant
Sending…
TG THERAPEUTICS, INC. — Director's Dealing 2007
Aug 2, 2007
31066_dirs_2007-08-02_46d0aba6-07e3-4aef-acde-20708497f68c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MANHATTAN PHARMACEUTICALS INC (MHA)
CIK: 0001001316
Period of Report: 2007-08-01
Reporting Person: WEISER MICHAEL (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2007-08-01 | Common Stock | A | 10000 | $0.26 | Acquired | 2247563 | Direct |
More from TG THERAPEUTICS, INC.
Regulatory Filings
2026
Jun 3
Regulatory Filings
2026
May 27
Earnings Release
2026
May 6
Capital/Financing Update
2026
Mar 20
Annual Report
2026
Feb 27
Earnings Release
2026
Feb 26
Director's Dealing
2026
Jan 29
Regulatory Filings
2026
Jan 13
Director's Dealing
2026
Jan 9
Director's Dealing
2026
Jan 9